SREBF2 and Alzheimer disease: In cellular experiments, it was demonstrated that Aβ, a prominent pathological hallmark in the brains of both APP/PS1 mice and individuals with AD [45,46], could impede the nuclear translocation of SREBP2 via the involvement of the AKT signaling pathway [18].